Pharmaron Beijing Co., Ltd. (SZSE:300759) agreed to acquire 50% stake in Zhaoqing Pharmaceutical Biotechnology Co., Ltd. from Shin Nippon Biomedical Laboratories (Asia) Ltd. on April 7, 2021. The financials of Zhaoqing Pharmaceutical Biotechnology for the year ended December 31, 2020, are total assets of CNY 47.52 million, net worth of CNY 24.78 million, revenues of CNY 4.93 million and operating loss of CNY million 2.47 million. The transaction is approve by the Board of Directors of Shin Nippon Biomedical Laboratories. The transaction is expected to be completed on April 7, 2021.